News

Tryton’s Side Branch Stent System is designed to offer a dedicated strategy for treating atherosclerotic lesions at the site of a bifurcation. The system will be available first

Under the terms of the agreement, which is subject to applicable regulatory clearances and customary conditions, Indevus will conduct and Teva will reimburse Indevus for its expenses for

Under the terms of this letter of intent (LOI), IDL will develop and manufacture the product which will be marketed and distributed by Breckenridge. The two companies plan

New data from a multi-center, randomized clinical trial indicate that the EndoBarrier is a safe, noninvasive device with excellent short-term weight loss results in morbidly obese patients. These

Nabumetone is a non-steroidal anti-inflammatory drug used to treat arthritis-related pain. Dr Reddy’s Laboratories is a pharmaceutical company that produces active pharmaceutical ingredients and intermediates, and finished dosage

Under the terms of the agreement, Shionogi will continue to have the right to use MorphoSys’s proprietary antibody library HuCAL Gold for research purposes at one of its

This program is intended to provide the technical and professional staff at Clarient with the necessary skills to provide superior clinical service using both standard and non-standard assays.

The 600sqft suite will enable the conjugation of high-potency active pharmaceutical ingredients (HPAPIs) to a variety of targeted delivery molecules, including monoclonal antibodies. In addition, the new facility

WuXi will maintain its original plan to construct, own and operate a 323,450sqft good laboratory practice (GLP) facility in Suzhou, China which is slated to open in the